EPS for MetLife, Inc. (MET) Expected At $1.27

October 14, 2018 - By olga

MetLife, Inc. (NYSE:MET) LogoInvestors sentiment increased to 0.89 in Q2 2018. Its up 0.17, from 0.72 in 2018Q1. It increased, as 48 investors sold MetLife, Inc. shares while 328 reduced holdings. 85 funds opened positions while 249 raised stakes. 751.98 million shares or 1.88% less from 766.37 million shares in 2018Q1 were reported.
Wetherby Asset Mngmt reported 15,004 shares or 0.09% of all its holdings. Paradigm Asset Com Ltd Limited Liability Company accumulated 68,230 shares. Arrowgrass Cap Prns (Us) L P holds 30,770 shares. Fukoku Mutual Life holds 297,050 shares or 1.84% of its portfolio. Moreover, Ls Invest Advsr Limited Liability has 0.1% invested in MetLife, Inc. (NYSE:MET). Wealthcare Capital Mngmt Lc owns 766 shares. 57,490 were reported by Cna Corporation. Windsor Mngmt Ltd Liability, a Arizona-based fund reported 13,823 shares. Andra Ap holds 132,500 shares. Leavell Inv Mngmt invested in 8,319 shares. Cadence Bankshares Na holds 0.22% or 12,552 shares in its portfolio. Carret Asset Mgmt Ltd Company accumulated 108,077 shares or 0.77% of the stock. Cubist Systematic Strategies Llc reported 94,333 shares or 0.21% of all its holdings. Nelson Van Denburg Campbell Wealth Mgmt Gp Limited Liability reported 0.03% stake. M Secs Inc invested in 5,238 shares or 0.06% of the stock.

Analysts expect MetLife, Inc. (NYSE:MET) to report $1.27 EPS on November, 7.They anticipate $0.18 EPS change or 16.51 % from last quarter’s $1.09 EPS. MET’s profit would be $1.26 billion giving it 8.63 P/E if the $1.27 EPS is correct. After having $1.30 EPS previously, MetLife, Inc.’s analysts see -2.31 % EPS growth. The stock increased 0.16% or $0.07 during the last trading session, reaching $43.83. About 8.87M shares traded or 71.41% up from the average. MetLife, Inc. (NYSE:MET) has declined 7.40% since October 14, 2017 and is downtrending. It has underperformed by 23.02% the S&P500.

MetLife, Inc. (NYSE:MET) Ratings Coverage

Among 7 analysts covering MetLife (NYSE:MET), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. MetLife had 8 analyst reports since April 25, 2018 according to SRatingsIntel. As per Friday, August 17, the company rating was maintained by Credit Suisse. The firm has “Neutral” rating by Goldman Sachs given on Monday, June 4. Deutsche Bank maintained it with “Hold” rating and $48 target in Friday, May 4 report. The firm has “Neutral” rating by FBR Capital given on Monday, July 16. The stock of MetLife, Inc. (NYSE:MET) earned “Neutral” rating by UBS on Monday, October 8. The stock of MetLife, Inc. (NYSE:MET) has “Equal-Weight” rating given on Wednesday, July 11 by Morgan Stanley. Barclays Capital maintained the stock with “Overweight” rating in Monday, July 9 report.

MetLife, Inc., through its subsidiaries, provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. The company has market cap of $43.60 billion. It operates in six divisions: U.S.; Asia; Latin America; Europe, the Middle East, and Africa; MetLife Holdings; and Brighthouse Financial. It has a 10.83 P/E ratio. The firm offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, and critical illness insurance products; vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only and private floating rate funding agreements; and account guaranteed, separate account guaranteed, and trust guaranteed interest contracts.

MetLife, Inc. (NYSE:MET) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>